Join
Live feed
·
PRReleasevia Quantisnow
Evotec SE logo

Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies

ByQuantisnow·Wall Street's wire, on your screen.
EVO· Evotec SE
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVO (Evotec SE) and more on Quantisnow.